Publication | Closed Access

Further insight on the hypoglycemic and nonhypoglycemic effects of troglitazone 400 or 600 mg/d: Effects on the very-low-density and high-density lipoprotein particle distribution

Metabolic SyndromeDiabetesPharmacologyNonhypoglycemic EffectsHyperlipidemiaLipoprotein MetabolismMedicineAtherosclerosisDyslipidemiaTroglitazone 400